XML 103 R87.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders' Equity (SARS Activity) (Details) - SARS - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Aug. 31, 2021
Aug. 31, 2020
SARS Outstanding    
SARS Outstanding as of beginning of period (in shares) 15,000  
SARS exercised (in shares) (15,000)  
SARS Outstanding as of end of period (in shares) 0 15,000
Aggregate intrinsic value, outstanding and exercisable $ 0 $ 235
Weighted- Average Exercise Price    
Weighted-Average Exercise Price, Outstanding as of beginning of period (in dollars per share) $ 18.49  
Weighted-Average Exercise Price, SARS exercised (in dollars per share) 18.49  
Weighted-Average Exercise Price, Outstanding as of end of period (in dollars per share) $ 0 $ 18.49
Weighted- Average Remaining Contractual Life, Outstanding (in years) 0 years 1 year 1 month 17 days